99 related articles for article (PubMed ID: 4099132)
1. [Contemporary treatment of diffuse toxic goiter].
Spesivtseva VG; Liashko KIa
Sov Med; 1970; 33(8):103-11. PubMed ID: 4099132
[No Abstract] [Full Text] [Related]
2. [Comparative curative effect of Mercasolyl and potassium perchlorate in treating patients with diffuse toxic goiter].
Anvarova ShS
Sov Med; 1972 Jul; 35(7):84-8. PubMed ID: 4115205
[No Abstract] [Full Text] [Related]
3. [Hyperthyroidism].
Cah Med; 1972 Dec; 13(17):1133-220. PubMed ID: 4121373
[No Abstract] [Full Text] [Related]
4. [Basedow's disease].
Kumahara Y
Naika; 1965 Aug; 16(2):332-4. PubMed ID: 4161079
[No Abstract] [Full Text] [Related]
5. [Combination of low doses of 131-iodine and synthetic antithyroid agents for prolonged treatment in Basedow's disease. Apropos of 165 cases].
Mitouze J; Jaffiol C; Baldet L; Ghachem M
Rev Fr Endocrinol Clin; 1972; 13(4):339-61. PubMed ID: 4122472
[No Abstract] [Full Text] [Related]
6. [The treatment of hyperthyroid syndromes. I. Specific therapy. (Clinico-statistical contribution)].
Donati GS; Guagliano G; Scotti-Foglieni C; Cortinovis R; Pedroni G; Molteni F
Chir Ital; 1967 Dec; 19(6):957-1106. PubMed ID: 4180460
[No Abstract] [Full Text] [Related]
7. [Use of thyrostatic preparations to reduce the radioresistance of toxic goiter during radioiodine treatment].
Livergant IuE; Suslina NG
Med Radiol (Mosk); 1968 Jul; 13(7):9-11. PubMed ID: 4190228
[No Abstract] [Full Text] [Related]
8. [Diffuse toxic goiter].
Starostina EG
Feldsher Akush; 1992 Jan; 57(1):28-33. PubMed ID: 1383041
[No Abstract] [Full Text] [Related]
9. [Basedow's disease].
Shizume K
Naika; 1971 Jun; 27(6):1156-8. PubMed ID: 4103929
[No Abstract] [Full Text] [Related]
10. [BASEDOW'S DISEASE. SIGNS, DIAGNOSIS AND TREATMENT].
SCHAISON G
Gaz Med Fr; 1964 May; 71():2025-41. PubMed ID: 14144650
[No Abstract] [Full Text] [Related]
11. [Antithyroid agents. 15].
Götz HG
Pharm Prax; 1967; 9():258-64. PubMed ID: 4183277
[No Abstract] [Full Text] [Related]
12. [Complex treatment of toxic goiter].
Kal'chenko II; Nechiporenko FP
Sov Med; 1973 Oct; 36(10):99-102. PubMed ID: 4133131
[No Abstract] [Full Text] [Related]
13. [Some recent progress in the medical treatment of hyperthyroidism].
Bricaire H; Joly J
Presse Med (1893); 1967 Jun; 75(29):1517-21. PubMed ID: 4165247
[No Abstract] [Full Text] [Related]
14. [Conservative treatment of diffuse toxic goiter].
Potin VV
Sov Med; 1979 Jun; (6):87-91. PubMed ID: 89703
[No Abstract] [Full Text] [Related]
15. Treatment of toxic diffuse goiter.
Stanbury JB
Postgrad Med; 1969 Jul; 46(1):137-9. PubMed ID: 4183010
[No Abstract] [Full Text] [Related]
16. [Medical treatment and therapeutic indications in hyperthyroidism].
Vague J
Cah Med; 1972 Dec; 13(17):1257-62. PubMed ID: 4121376
[No Abstract] [Full Text] [Related]
17. [On the residual thyroid tissue after thyroidectomy for diffuse goiter with thyrotoxicosis].
Angelescu E; Stoenescu D; Damian A; Taşcă C
Stud Cercet Endocrinol; 1973; 24(6):465-71. PubMed ID: 4129363
[No Abstract] [Full Text] [Related]
18. [Current approaches to the treatment of diffuse toxic goiter].
Balabolkin MI
Ter Arkh; 1995; 67(10):15-8. PubMed ID: 8779095
[No Abstract] [Full Text] [Related]
19. A round table discussion. Goiter: the therapeutic choices.
Schultz AL; Beahrs OH; McConahey WM; Nuttall FQ; Wong ET
Geriatrics; 1973 Jul; 28(7):80-96. PubMed ID: 4122973
[No Abstract] [Full Text] [Related]
20. Autoimmune response to the antithyroid and 131-I therapy of hyperthyroidism.
Takó J; Bános C
Endokrinologie; 1971 Apr; 57(3):400-4. PubMed ID: 4103579
[No Abstract] [Full Text] [Related]
[Next] [New Search]
